Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's disease through a single administration. It provides Strimvelis, a gammaretroviral-based product for the treatment of adenosine deaminase-severe combined immunodeficiency (ADA-SCID). The company's clinical development products comprise OTL-101 for the treatment of ADA-SCID; OTL-200 to treat metachromatic leukodystrophy; OTL-103 for the treatment of Wiskott-Aldrich syndrome; OTL-102 for X-linked chronic granulomatous disease; and OTL-300 for transfusion-dependent beta-thalassemia. Its preclinical programs include OTL-203 for mucopolysaccharidosis type I, OTL-201 for mucopolysaccharidosis type MPS-IIIA, and OTL-202 for mucopolysaccharidosis type IIIB. It has a strategic collaboration agreement with Pharming Group N.V. for research, development, manufacturing, and commercialization of OTL-105, an investigational ex vivo autologous hematopoietic stem cell gene therapy for the treatment of hereditary angioedema. The company was formerly known as Orchard Rx Limited. Orchard Therapeutics plc was founded in 2015 and is headquartered in London, the United Kingdom. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Orchard Therapeutics plc American Depositary Shares.
Orchard Therapeutics plc American Depositary Shares business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Orchard Therapeutics plc American Depositary Shares are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Orchard Therapeutics plc American Depositary Shares , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Orchard Therapeutics plc American Depositary Shares including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Orchard Therapeutics plc American Depositary Shares and all latest updates of the company are provided.
The 2025 version of Orchard Therapeutics plc American Depositary Shares report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Orchard Therapeutics plc American Depositary Shares- Key Facts
2.2 Orchard Therapeutics plc American Depositary Shares- Geographic Locations
2.3 Orchard Therapeutics plc American Depositary Shares- Subsidiaries and Affiliates
2.4 Orchard Therapeutics plc American Depositary Shares- Business Divisions
2.5 Orchard Therapeutics plc American Depositary Shares- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Orchard Therapeutics plc American Depositary Shares Strategic Analysis Review
3.1 Orchard Therapeutics plc American Depositary Shares- Key Strategies
3.2 Orchard Therapeutics plc American Depositary Shares- Company Outlook Statement
3.3 Orchard Therapeutics plc American Depositary Shares- SWOT Analysis
3.3.1 Orchard Therapeutics plc American Depositary Shares- Key Strengths
3.3.2 Orchard Therapeutics plc American Depositary Shares- Key Weaknesses
3.3.3 Orchard Therapeutics plc American Depositary Shares- Potential Opportunities
3.3.4 Orchard Therapeutics plc American Depositary Shares- Potential Threats
3.4 Orchard Therapeutics plc American Depositary Shares- Key Competitors
4. Business Description of the Company
4.1 Orchard Therapeutics plc American Depositary Shares- Business Overview
4.2 Orchard Therapeutics plc American Depositary Shares- Operations by Segment
5 Products and Services Details
5.1 Orchard Therapeutics plc American Depositary Shares- Key Products
5.2 Orchard Therapeutics plc American Depositary Shares- Key Service Areas
5.3 Orchard Therapeutics plc American Depositary Shares- Key Brands
6 Company Developments
6.1 Orchard Therapeutics plc American Depositary Shares- Company History
6.2 Orchard Therapeutics plc American Depositary Shares- Latest Developments
7 Financial Analysis
7.1 Orchard Therapeutics plc American Depositary Shares- Income Statements
7.2 Orchard Therapeutics plc American Depositary Shares- Balance Sheet
7.3 Orchard Therapeutics plc American Depositary Shares- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Orchard Therapeutics plc American Depositary Shares- Direct Competitors
8.2 Orchard Therapeutics plc American Depositary Shares- Competitor Financial Ratios comparison
8.3 Orchard Therapeutics plc American Depositary Shares- Competitor Stock Charts Comparison
8.4 Orchard Therapeutics plc American Depositary Shares- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
